JE-2147 | Interleukin Related interleukin-related.com

Product Name :
JE-2147

Search keywords :
JE-2147

drugId :
null

Target Vo:
Human immunodeficiency virus type 1 protease

Target Vo Short Name :
HIV-1 protease

Moa_Name:
Human immunodeficiency virus type 1 protease inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sumitomo Dainippon

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
HIV Infections

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ixekizumab Technical Information
Penpulimab Cancer
Caspase 7 Antibody: Caspase 7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Caspase 7. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Mouse, Rat.

Author: Interleukin Related

Related Posts